# Metabolism of Deuterated NNN in Smokeless Tobacco Users

> **NCT02414477** · PHASE1 · TERMINATED · sponsor: **University of Minnesota** · enrollment: 13 (actual)

## Conditions studied

- Tobacco Toxicant Exposure

## Interventions

- **DRUG:** Deuterated NNN

## Key facts

- **NCT ID:** NCT02414477
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-04-15
- **Primary completion:** 2020-02-21
- **Final completion:** 2020-02-21
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** not successful in securing the deuterated products
- **Last updated:** 2025-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02414477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02414477, "Metabolism of Deuterated NNN in Smokeless Tobacco Users". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02414477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*